| 영문 | thyroid carcinoma | 한글 | 갑상샘암종 |
|---|---|---|---|
| 설명 | 갑상샘에 생긴 상피세포로 이루어진 악성종양물. 병리조직학적인 형태에 따라 유두상, 소포상, 역형암종 및 수질암종, 림프종 등으로 나눌 수 있다. 다양한 원인이 있으나, 일부에서는 방사선폭로에 의해 발생한다. 치료는 수술, 방사성 옥소, T4 억제요법 등이 사용된다. |
||
| 영문 | bronchogenic carcinoma | 한글 | 기관지원성 암종 |
|---|---|---|---|
| 설명 | 폐의 기관지 세포에서 기원하는 종양. 폐암의 종류에서 가장 흔한 형태(90%이상)이다. 현미경적 소견에 따라 샘암종, 큰세포암종, 소세포(작은세포) 암종의 4가지로 나눈다. 이중에서 편평세포암종이 가장 흔한 형태이다. 임상적으로는 비소세포폐암(non-small cell lung cancer)와 소세포폐암(small cell lung cancer)로 구분을 하는데, 비소세포폐암의 경우 종양세포의 성장이 느리고 수술적 제거가 치료의 기본이 되고 예후도 좋은 반면, 소세포폐암의 경우에는 암세포의 성장이 매우 빠르고 치료도 방사선치료를 기본으로 하며 예후도 비소세포폐암에 비해서 좋지가 못하다. |
||
| 영문 | embryonal carcinoma | 한글 | 배아암종 |
|---|---|---|---|
| 설명 | 생식세포에서 생기는 암종의 하나로 대부분 고환에서 발생한다. 드물게는 종격동에서도 발생한다. 40~50대의 남성에게 많으나, 이보다 낮은 연령층에서도 나타난다. 육안적으로는 회백색의 분엽을 보이는 덩어리를 형성하며, 고환 악성 종양 중 예후가 좋은 편이다. 치료의 원칙은 가급적 신속하게 원발소를 절제하고 예상되는 전이병터에 대하여 방사선 조사요법을 행해야 한다. 태생암종 방사선요법에 대하여 매우 감수성이 높기 때문에 병기가 초기이면 90% 이상의 치료가 기대된다. 그리고 화학요법제에 의해 그 치료성과가 상승하고 있다. |
||
| 영문 | carcinoma in situ | 한글 | 상피내암종 |
|---|---|---|---|
| 설명 | 신체의 내부나 외부를 쌓고 있는 조직을 상피라고 한다. 이 상피의 아래에는 대개 상피를 지지하고 있는 조직의 위에 존재한다. 그리고 이 지지조직과 상피 사이에는 기저막이라는 막이 있어서 상피와 지지조직을 구분해 준다. 암종(carcinoma)란 상피의 세포가 악성 변화를 하여 생기는 암을 말한다. 제자리암종이란 암종의 한 종류로 암종이 기저막을 벗어나지 못하고 상피내 즉, 제자리에 머물러 있는 경우를 말한다. |
||
| 영문 | carcinoma | 한글 | 암종 |
|---|---|---|---|
| 설명 | 암종이란 상피세포(-신체의 내부나 외부를 쌓고 있는 조직을 상피라고 하고, 상피를 이루고 있는 세포를 상피세포라고 한다)의 과도한 증식에의한 악성종양을 이르는 말이다. |
||
| ACC | accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst... |
|---|---|
| EAC | Ehrlich ascites carcinoma; electroacupuncture; epithelioma adenoides cysticum; erythema annulare cen... |
| EAT | Eating Attitudes Test; Ehrlich ascites tumor; electro-aerosol therapy; epidermolysis acuta toxica; e... |
| EATC | Ehrlich ascites tumor cell |
| EU | Ehrlich unit; elementary unit; emergency unit; endotoxin unit; entropy unit; enzyme unit; esterase u... |
| EATC | Ehrlich Ascites tumour cells |
|---|---|
| EAC | Ehrlich Ascites Carcinoma |
| EA | Ehrlich Ascites |
| EAT | Ehrlich Ascites Tumor |
| TNF alpha | Anti-tumour necrosis factor alpha |
| carcinoma, ehrlich tumour | A transplantable, poorly differentiated malignant tumour which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. (12 Dec 1998) |
|---|
| Paul Ehrlich | <person> A brilliant scientist and student, born in Silesia, Germany, who at the age of 23 published his first scientific paper which was on the discovery of the mast cells - a name coined by him (1887). While a resident in medicine at Charite Hospital in Berlin he utilised the newly discovered aniline dyes to develop some of the basic methods of histology. Among his contributions are: The preparation and staining of blood smears, he demonstrated granules in leukocytes, described the neutrophil, basophil, eosinophil, myelocyte, and mononuclear cells (white blood cells), he demonstrated normoblasts, megaloblasts and microblasts of the erythrocytic (red blood cell) series. In 1887, he differentiated lymphocytic leukaemia from "bone marrow leukaemia" (myeloid) on blood smear, in 1888, he described aplastic anaemia, in 1882 the diazo reaction of typhoid urines, in 1882, less than six weeks after Koch described the Tuberculus bacillus, Ehrlich had described its acid-fastness and devised the fuchsin stain to demonstrate the pink rod on a blue background. Ehrlich fell ill with tuberculosis and went to Egypt for 3 years for rest and cure. Following his return, he entered the field of immunology. at Von Behring's request, he developed means of standardising antitoxin dosage (immunization units). at the age of 42, he became director of the "Royal Institute for Standardisation and Investigation of Antitoxic Sera." Here he devised his famous "side-chain" theory of immunisation. It has since been replaced. Paul Ehrlich reinvestigated Bordet's alexin and heat-stable substance and named them "complement" and "immune body". Ehrlich coined the terms and created a new science of chemotherapy. In 1910 he discovered Salvarsan or 606, a therapeutic antiluetic. For his silver bullet (Salvarsan) in 1908, he received the Nobel Prize. This scientist was greatly concerned over the problem of drug fastness which still remains a problem. He died August 20, 1915. Lived: 1854-1915. (18 Nov 1997) |
|---|---|
| Heinz-Ehrlich body | A round oxyphil body found in the red blood cell in case of haemocytolysis due to a specific blood poison. Synonym: Heinz-Ehrlich body. (05 Mar 2000) |
| Ehrlich | Paul, German bacteriologist, immunologist, and Nobel laureate, 1854-1915. See: Ehrlichia, Ehrlich's anaemia, Ehrlich's inner body, Ehrlich's phenomenon, Ehrlich's postulate, Ehrlich's diazo reagent, Ehrlich's theory, Ehrlich-Turk line. See entries under stain; reaction. (05 Mar 2000) |
| Ehrlich, Paul | <person> A brilliant scientist and student, born in Silesia, Germany, who at the age of 23 published his first scientific paper which was on the discovery of the mast cells - a name coined by him (1887). While a resident in medicine at Charite Hospital in Berlin he utilised the newly discovered aniline dyes to develop some of the basic methods of histology. Among his contributions are: The preparation and staining of blood smears, he demonstrated granules in leukocytes, described the neutrophil, basophil, eosinophil, myelocyte, and mononuclear cells (white blood cells), he demonstrated normoblasts, megaloblasts and microblasts of the erythrocytic (red blood cell) series. In 1887, he differentiated lymphocytic leukaemia from "bone marrow leukaemia" (myeloid) on blood smear, in 1888, he described aplastic anaemia, in 1882 the diazo reaction of typhoid urines, in 1882, less than six weeks after Koch described the Tuberculus bacillus, Ehrlich had described its acid-fastness and devised the fuchsin stain to demonstrate the pink rod on a blue background. Ehrlich fell ill with tuberculosis and went to Egypt for 3 years for rest and cure. Following his return, he entered the field of immunology. at Von Behring's request, he developed means of standardising antitoxin dosage (immunization units). at the age of 42, he became director of the "Royal Institute for Standardisation and Investigation of Antitoxic Sera." Here he devised his famous "side-chain" theory of immunisation. It has since been replaced. Paul Ehrlich reinvestigated Bordet's alexin and heat-stable substance and named them "complement" and "immune body". Ehrlich coined the terms and created a new science of chemotherapy. In 1910 he discovered Salvarsan or 606, a therapeutic antiluetic. For his silver bullet (Salvarsan) in 1908, he received the Nobel Prize. This scientist was greatly concerned over the problem of drug fastness which still remains a problem. He died August 20, 1915. Lived: 1854-1915. (18 Nov 1997) |
| Ehrlich reaction | The reaction of the indole derivatives with aromatic aldehydes; e.g., tryptophan and p-dimethylaminobenzaldehyde in H2SO4 give a red-violet colour useful in assaying proteins for tryptophan content. Synonym: Ehrlich reaction. (05 Mar 2000) |
| Ehrlich's acid haematoxylin stain | <technique> An alum type of haematoxylin stain used as a regressive staining method for nuclei, followed by differentiation to required staining intensity; the solution may be allowed to ripen naturally in sunlight or partially oxidised with sodium iodate. (05 Mar 2000) |
| Ehrlich's anaemia | <haematology> This form of anaemia occurs when the bone marrow ceases sufficient red and white blood cell production. It may be induced by exposures to high levels of toxic chemicals, radiation and certain drugs. It is generally unresponsive to specific therapy, often accompanied by granulocytopenia and thrombocytopenia, in which the bone marrow may not necessarily be hypocellular or hypoplastic but fails to produce adequate numbers of peripheral blood elements. The term actually is all inclusive and most probably encompasses several clinical syndromes. Origin: Gr. Haima = blood (29 Sep 1997) |
| Ehrlich's aniline crystal violet stain | <technique> A stain for Gram-positive bacteria. (05 Mar 2000) |
| Ehrlich's benzaldehyde reaction | A test for urobilinogen in the urine, by dissolving 2 g of dimethyl-p-aminobenzaldehyde in 100 ml of 5% hydrochloric acid and adding this reagent to urine; a red colour in the cold indicates the presence of an excessive amount of urobilinogen. (05 Mar 2000) |
| Ehrlich's diazo reaction | The reaction of diazotised sulfanilic acid with bilirubin to form azobilirubin, which forms the basis of quantitating the amount of bilirubin in biological fluids. See: van den Bergh's test. Synonym: Ehrlich's diazo reaction. (05 Mar 2000) |
| Ehrlich's diazo reagent | Two solutions, one of sodium nitrite, the other of acidified sulfanilic acid, used in bringing about diazotization. Synonym: Ehrlich's diazo reagent. (05 Mar 2000) |
| Ehrlich's inner body | A round oxyphil body found in the red blood cell in case of haemocytolysis due to a specific blood poison. Synonym: Heinz-Ehrlich body. (05 Mar 2000) |
| Ehrlich's phenomenon | The difference between the amount of diphtheria toxin that will exactly neutralise one unit of antitoxin and that which, added to one unit of antitoxin, will leave one lethal dose free is greater than one lethal dose of toxin; i.e., it is necessary to add more than one lethal dose of toxin to a neutral mixture of toxin and antitoxin to make the mixture lethal (the basis of the L+ dose). (05 Mar 2000) |
| Ehrlich's postulate | Ehrlich postulated that cells contained surface extensions or side chains (haptophores) that bind to the antigenic determinants of a toxin (toxophores); after a cell is stimulated, the haptophores are released into the circulation and become the antibodies. See: receptor. Synonym: Ehrlich's postulate. (05 Mar 2000) |
| Ehrlich's theory | Ehrlich postulated that cells contained surface extensions or side chains (haptophores) that bind to the antigenic determinants of a toxin (toxophores); after a cell is stimulated, the haptophores are released into the circulation and become the antibodies. See: receptor. Synonym: Ehrlich's postulate. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|